PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
31-Mar-2025 Simulab Corporation Announces Promotion of Woody Salmonsen to Director of Sales, North America ACCESS NewsWire
31-Mar-2025 Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year ACCESS NewsWire
31-Mar-2025 Interactive Strength Inc. (Nasdaq: TRNR) Reports Fourth Quarter & Year-End 2024 Results ACCESS NewsWire
31-Mar-2025 Moderna Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults ACCESS NewsWire
31-Mar-2025 Black Book Research Identifies Top Global Growth Opportunities for openEHR Adoption in 2025 ACCESS NewsWire
31-Mar-2025 Biotest AG: Delisting agreement and announced delisting tender offer Biotest AG
31-Mar-2025 Drägerwerk AG & Co. KGaA: Dräger increases net profit in fiscal year 2024 and raises dividend Drägerwerk AG & Co. KGaA
31-Mar-2025 Biotest AG increases sales by 6% in financial year 2024 Biotest AG
31-Mar-2025 BIOVERSYS ANNOUNCES IMPORTANT BV100 PATENT GRANTED BY CHINESE PATENT OFFICE BioVersys AG
31-Mar-2025 AEVIS VICTORIA SA - Infracore strengthens its balance sheet and prepares for accelerated growth in 2025 AEVIS VICTORIA SA
31-Mar-2025 Empowering Research: Sirius Fine Chemicals Boosts Product Credibility With Bioz AI-Driven Citation Badges ACCESS NewsWire
31-Mar-2025 Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights ACCESS NewsWire
30-Mar-2025 DEA Forces Marijuana Pharma Drug Industry Offshore: A Symbol of DEA Systemic Obstruction Against Trump Administration Directives ACCESS NewsWire
29-Mar-2025 CPC Announces Semaglutide Significantly Improves Walking Distance, Symptoms and Quality of Life for People with PAD and Diabetes ACCESS NewsWire
29-Mar-2025 BOC Sciences Returns to Drug Discovery Chemistry 2025, Seeking Broad Partnerships BOC Sciences
28-Mar-2025 Lifeloc Technologies Reports 2024 Full Year Results ACCESS NewsWire
28-Mar-2025 Strategic update on the progress and development of Molecure's key clinical projects in 2024 Molecure
28-Mar-2025 Nutraceuticals Market Hits $416 Billion in 2021, Expected to Grow at 8–9% by 2026 Medi-Tech Insights
28-Mar-2025 Solaxa Announces Phase 3 Clinical Trial for Spinocerebellar Ataxia Type 27B ACCESS NewsWire
28-Mar-2025 The Future of Physical Therapy: Trends to Watch in 2025 and Beyond ACCESS NewsWire